Given its usefulness for studying the pathophysiology of MS and for evaluating potential remyelinating or neuroprotective therapies, the CPZ-induced model enabled us to investigate the role of Apo D within this physiologically relevant context by assessing its expression in the corpus callosum following CPZ administration. Here, APOD is linked to myeloid sarcoma.